[1]Confavreux C, Vukusic S.Natural history of multiple sclerosis: a unifying concept [J].Brain, 2006,129(3):606-616.
[2]Steinman L.Immune therapy for autoimmune diseases [J].Science, 2004, 305(5681): 212-216.
[3]Weber MS, Youssef S, Dunn SE, et al.Statins in the treatment of central nervous system autoimmune disease[J].J Neuroimmunol,2006, 178(1-2):140-148.
[4]Luccarini I,Ballerini C,Biagioli T,et al.Combined treatment with atorvastatin and minocycline suppresses severity of EAE [J].Exp Neurol, 2008, 211(1): 214-226.
[5] Paintlia AS, Paintlia MK, Singh AK, et al.Inhibition of rho family functions by lovastatin promotes myelin repair in ameliorating experimental autoimmune encephalomyelitis [J].Mol Pharmacol, 2008,73(5):1381-1393.
[6]Fu YF,Wang JX,Zhao Y,et al.S-Adenosyl-l-homocysteine hydrolase inactivation curtails ovalbumininduced immune responses [J].J Pharmacol Exp Ther, 2006, 316(3):1229-1237.
[7]Peterson JW,Trapp BD.Neuropathobiology of multiple sclerosis [J].Neurologic Clin, 2005,23(1):107-129.
[8]Gold R,Linington C,Lassmann H.Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research [J].Brain, 2006, 129(8):1953-1971.
[9]Bettelli E,Das MP,Howard ED,et al.IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice [J].J Immunol, 1998, 161(7): 3299-3306.
[10]Yang JX, Jiang ZL, Fitzgerald DC, et al.Adult neural stem cells expressing IL-10 confer potent immunomodulation and remyelination in experimental autoimmune encephalitis [J].J Clin Invest, 2009, 119(12): 3678-3691.
[11]Wang Y, Mei YH, Feng DC, et al.Triptolide modulates T-cell inflammatory responses and ameliorates experimental autoimmune encephalomyelitis [J].J Neurosci Res, 2008, 86 (11): 2441-2449.
[12]Fu FY, Zhu NY, Ni J, et al.(5R)-5-Hydroxytriptolide (LLDT-8), a novel triptolide derivative, prevents experimental autoimmune encephalomyelitis via inhibiting T cell activation [J].J Neuroimmunol, 2006, 175(1-2):142-151.
[13]Stuve O, Prod’homme T, Youssef S, et al.Statins as potential therapeutic agents in multiple sclerosis [J].Curr Neurol Neurosci Rep,2004, 4(3):237-244.
[14]陈卫兵,蒲 红,黄丽娜.早期应用辛伐他汀治疗急性冠状动脉综合征临床观察及对炎症因子的影响[J].东南国防医药,2003,5(5):330-332.
[15]丁雪燕,罗助荣.急性冠脉综合征血清脑钠肽水平及阿托伐他汀对其影响[J].东南国防医药,2009,11(1):37-39.